CryoPort (CYRX) has agreed to sell its CRYOPDP unit, a specialty courier focused on clinical trials, biopharma, and cell and gene therapies, to DHL Group, according to a Monday statement from the companies.
No financial terms were disclosed. The companies said they also agreed to form a strategic partnership to strengthen their supply chain services for the global life sciences and healthcare sector.
CryoPort said it also expects the partnership with DHL to support its business in the Asia Pacific and Europe, the Middle East and Africa regions.
The sale and and the partnership remain subject to regulatory approvals, according to the companies.
Price: 6.41, Change: +0.32, Percent Change: +5.25
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。